Determination of the number of observers needed to evaluate a subjective test and its application in two PD‐L1 studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determination of the number of observers needed to evaluate a subjective test and its application in two PD‐L1 studies

Published:2021-12-12 Issue: Volume: Page:
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Han Gang¹^ORCID,Schell Michael J.²,Reisenbichler Emily S.³,Guo Bohong¹,Rimm David L.⁴

Affiliation:

1. Department of Epidemiology and Biostatistics Texas A&M University School of Public Health College Station Texas USA

2. Department of Biostatistics and Bioinformatics Moffitt Cancer Center & Research Institute Tampa Florida USA

3. Department of Pathology Saint Louis University School of Medicine St. Louis Missouri USA

4. Department of Pathology Yale University School of Medicine New Haven Connecticut USA

Funder

Yale SPORE in Lung Cancer

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9282

Reference26 articles.

1. Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods

2. Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration

3. Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer

4. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of Oestrogen and progesterone receptor levels in breast cancer;Rexhepaj E;Breast Cancer Res,2008

5. Prospective multi‐institutional evaluation of pathologist assessment of PD‐L1 assays for patient selection in triple negative breast cancer;Reisenbichler ES;Mod Pathol,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett’s Esophagus;Diagnostics;2024-09-10

2. Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides;Breast Cancer Research;2024-08-19

3. Measuring disability among U.S. adolescents and young adults: A survey measurement experiment;Preventive Medicine Reports;2024-07

4. Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction Cancer;Modern Pathology;2023-05

5. Breast Cancer Pathology in the Era of Genomics;Hematology/Oncology Clinics of North America;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3